More results...

logo_oncodesign_services_blanc_couleurs

More results...

Contact
  • Discovery Services
    • Structural Biology
    • Medicinal Chemistry
    • In Vitro biology
    • DMPK
    • Bioanalysis, Formulation, Immunogenicity and Biomarkers
    • Bioconjugation and Radiochemistry Platform
    • In Vivo Pharmacology
    • In Vivo Imaging
  • Oncology
    • Immuno-Oncology
    • Tumor Models
    • Orthotopic Models
    • Metastatic Models
    • Humanized Models
    • Radiopharmaceutical Development
  • Inflammation
    • Autoimmunity Models
    • Dermal Models
    • Endometriosis Models
    • IBD Models
    • Kidney Models
    • Liver Models
    • Lung Models
    • Systemic Inflammation Models
  • Microbiome
  • Resources
  • Join us!
    • Job offers
    • Our HR Policy
  • About us
    • Our history
    • Management
    • Our CSR approach
    • Network
    • News
Contact
  • EXPLORE: Identification and validation of therapeutic targets
  • DRIVE-IDDS: integrated drug discovery solution
  • INPACT: integrated services in preclinical pharmacology
  • SOLO: offers from our innovative technical platforms
  • D-VLOP: bringing your drug to IND filing
Home . Oncodesign opens exclusive negotiations with Bertin Pharma for the acquisition of service businesses . Page 9

News

Financial Press Release | Oncodesign
Press release
18/12/2017

Promising clinical results for innovative mutated anti-EGFR radiotracer in patients with non-small cell lung cancer

Read more
Financial Press Release | Oncodesign
17/12/2017

US – Oncodesign has entered into a services agreement with Eisai to develop a new personalized medicine program in earlier line metastatic breast cancer treatment

Read more
Financial Press Release | Oncodesign
Press release
05/12/2017

Oncodesign reports positive results for its MNK1/2 program

Read more
Financial Press Release | Oncodesign
Press release
15/11/2017

Oncodesign announces positive results opening the way for the ALK1 program to advance to the lead optimization phase

Read more
Financial Press Release | Oncodesign
Press release
18/10/2017

OncoSNIPE® artificial intelligence project officially launched

Read more
Financial Press Release | Oncodesign
Press release
05/10/2017

Oncodesign launches its new website

Read more
Financial Press Release | Oncodesign
Press release
31/08/2017

Oncodesign announces the acquisition of Bertin Pharma’s pharmaceutical and biotech services businesses

Read more
Financial Press Release | Oncodesign
Press release
10/05/2017

Oncodesign opens exclusive negotiations with Bertin Pharma for the acquisition of service businesses

Read more
Financial Press Release | Oncodesign
Press release
03/04/2017

Oncodesign presents its latest scientific developments at the AACR annual global meeting on oncology

Read more
Financial Press Release | Oncodesign
Press release
30/03/2017

Business update and FY 2016 results

Read more
Financial Press Release | Oncodesign
Press release
15/03/2017

Oncodesign announces return of research collaboration and option to license rights for Parkinson program from Ipsen

Read more
Ressources presse
13/02/2017

[FR] Biotech – OncoSNIPE un ultra-générateur d’activités pour Oncodesign

Read more
1 2 … 8 9 10 … 13 14

Contact-us

20 rue Jean Mazen - FR - 21000 Dijon
Tel.+33 380 788 260

Get in touch

Science within easy reach!

Receive our general news!

Explore Oncodesign Services vitality
logo_oncodesign_services_blanc_couleurs

Follow us

linkedin twitter Stand with Ukraine
  • Discovery Services
    • Medicinal Chemistry
    • In Vitro biology
    • DMPK
    • In Vivo Pharmacology
  • Therapeutic areas
    • Oncology
    • Inflammation
  • Integrated Solutions
    • Small Molecule
    • Molecular Radiotherapy
    • Biologics
  • Legal notice
  • Personal data policy
  • General Terms And Conditions Of Purchase
  • Contact